Gene Query: MYO5C

Dataset Description Geneva Score
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 69.6
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 69.6
WRN knockout effects upon gene expression in SW48 and OVK18 44.96
Genes significantly down or Up-regulated upon RNF219 knockdown 43.3
Genome wide expression change in LCC2 and MCF-7 cells 38.81
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 37.55
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 32.8
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 32.8
TGF-β promotes genomic instability after loss of RUNX3 30.86
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 30.19
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 30.03
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 30.03
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 29.64
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 29.45
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 27.32
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 27.17
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 26.05
ARS2 is a general suppressor of pervasive transcription [RNAseq] 25.47
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 25.32
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 23.6
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 23.33
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 21.17
ARID1A regulates condensin II distribution and chromosomal partition 21.17
RNA-seq of YB5 cells treated with Proscillaridin A 20.71
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 20.51
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 20.45
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 20.34
snRNAs as regulators of alternative splicing 20.0
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 19.7
RNA-Seq analysis of breast cancer cells after shikonin treatment 19.28
Nutritional control of protein translation 19.25
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 18.86
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 18.82
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 18.81
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 18.51
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 18.05
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 17.62
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 17.19
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 16.98
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 16.78
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 16.71
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 16.6
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 16.56
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 16.18
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 16.05
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 15.58
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 15.42
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 15.42
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 15.38
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 15.27
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 15.0
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 14.96
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 14.8
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 14.8
RNA-Seq from early time points in the kidney differentiation protocol 14.69
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 14.54
A prostate cancer chromatin interaction map 14.23
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 14.19
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 14.08
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 14.02
Gene expression profile in breast cancer cell lines using RNA sequencing 13.99
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 13.75
RNA-seq of human aneuploid cell lines with Trisomy 21 13.65
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 13.64
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 13.59
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 13.59
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 13.41
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 13.37
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 13.35
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 13.35
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 13.35
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 13.24
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 13.24
Depicting early human development and germ cell origin with porcine embryos 13.06
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 12.92
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 12.91
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 12.54
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 12.46
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 12.44
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 12.35
Identifying the molecular mode of action of itraconazole in colorectal cancer 12.27
RNAseq Study in CC-671 Treated Cal-51 Cells 12.14
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 12.14
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 11.96
Effect of Influenza virus infection on lncRNA expression in A549 cells 11.91
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 11.86
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 11.82
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 11.82
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 11.79
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 11.79
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 11.59
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 11.59
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 11.54
Transcriptome analysis of BAP1 knockout and restoration 11.46
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 11.46
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 11.4
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 11.4
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 11.4
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 11.27
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 11.27
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 11.26
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 11.17
High-Throughput Kinetic Analysis of Fractional Killing 11.14
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 11.05
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 10.87
LNCaP treated with iBET 10.81
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 10.71
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 10.61
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 10.61
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 10.51
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 10.45
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 10.45
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 10.41
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 10.41
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 10.41
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 10.39
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 10.37
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 10.37
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 10.36
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 10.14
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 10.13
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.12
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 10.1
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 10.07
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 10.07
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 9.86
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 9.85
Transcriptome of EBV-infected gastric cancer cell lines 9.84
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 9.82
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 9.76
Reprogrammed myeloid cell transcriptomes in NSCLC 9.71
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 9.65
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 9.62
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 9.6
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 9.6
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 9.49
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 9.49
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 9.43
Genome-wide Analysis of Chromatin Interactions in Human Cells 9.26
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 9.24
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 9.24
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 9.21
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 9.13
Altering cancer transcriptomes using epigenomic inhibitors 9.13
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 9.1
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 9.03
The effect of insulin on mRNA transcription of human pluripotent stem cells 9.01
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 8.99
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 8.99
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 8.95
Knockdown of ADNP in HCT116 colon cancer cells 8.94
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 8.8
Expression profiling of MCF-7 cells with treatment of TCDD 8.8
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 8.76
Electronic cigarettes 8.72
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 8.61
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 8.6
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 8.58
A549 cells and MSR-A549 cells 8.5
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 8.5
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.48
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 8.48
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 8.47
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 8.45
NR2F2 study 8.44
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 8.44
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 8.43
Genome-wide functional assessment of enhancer activities in the human genome 8.42
EP400 is required for Max and MCPyV mediated gene activation 8.42
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 8.41
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 8.38
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 8.36
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 8.18
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 8.18
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 8.1
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 8.09
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 8.04
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 8.03
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 8.03
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 8.02
Gene expression profiling in metabolically heterogeneous human lung tumors 7.9
RNA-seq of MCF10A cells and CAF 7.9
METTL3 promotes translation in human cancer cells 7.88
Toxoplasma gondii infection of human retinal pigment epithelial cells 7.88
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 7.88
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 7.88
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 7.87
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 7.85
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 7.83
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 7.78
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.66
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 7.66
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 7.6
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 7.58
Searching for target genes of miR-508/509/506/514 in HCT116 cells 7.54
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.52
Effect of PBK knockdown on C4-2 cell transcriptome 7.51
Lipid degradation promotes prostate cancer cell survival 7.51
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 7.48
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 7.48
Comparing gene expression in iPSC derived RPE from control and AMD donors 7.47
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 7.47
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 7.39
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.37
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.35
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 7.33
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 7.32
Human embryonic stem cells in E8 and AKIT culture medium 7.32
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 7.29
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 7.12
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 7.09
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.07
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 7.03
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 7.02
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 6.97
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 6.95
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.92
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 6.92
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 6.89
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 6.87
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 6.85
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 6.85
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 6.85
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 6.81
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 6.76
NRDE2 negatively regulates nuclear exosome functions 6.74
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 6.72
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 6.72
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.71
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 6.71
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 6.7
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 6.7
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 6.64
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 6.63
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 6.61
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 6.59
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 6.59
Fibroblasts in cholesteatoma activate osteoclasts. 6.58
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 6.57
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.57
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.57
Functional astrocytes differentiated from hiPSCs 6.56
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 6.51
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.48
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.48
Transciptomic profiling of human fetal lung samples 6.4
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.39
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 6.33
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 6.32
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 6.32
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 6.31
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 6.24
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.21
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.21
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 6.2
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 6.16
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 6.14
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 6.11
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 6.1
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 6.07
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 6.06
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 6.02
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 6.0
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 6.0
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 6.0
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.97
Role for citron kinase in prostate cancer growth 5.92
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 5.88
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.84
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 5.81
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 5.79
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 5.79
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 5.75
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 5.73
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 5.73
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 5.71
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 5.71
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 5.67
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.54
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.54
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 5.54
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 5.52
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 5.51
Fusion discovery in breast cancer cell line 5.44
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 5.43
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 5.43
Dtx3L and Androgen Signaling in Prostate Cancer 5.38
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 5.37
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 5.36
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 5.32
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.29
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 5.28
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 5.24
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.23
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 5.22
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.22
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 5.22
Genome-wide discovery of human splicing branchpoints [RNAse] 5.15
RNA-Seq of the corpus callosum from 12 individuals 5.14
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 5.12
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 5.09
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 5.06
Paxillin regulates genomic networks in prostate cancer [C4-2] 5.05
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 5.04
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.04
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 4.96
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 4.9
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 4.9
Genome-wide discovery of human splicing branchpoints 4.89
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.83
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 4.82
ARID1A and ARID1B loss in HCT116 cells 4.79
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.78
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.78
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 4.77
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.77
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 4.76
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 4.53
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 4.51
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 4.51
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 4.5
SNHG5 siRNA knock down in HCT116 cells 4.47
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 4.46
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 4.45
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 4.45
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 4.44
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 4.43
JunB control of keratinocyte-mediated inflammation [RNA-seq] 4.43
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 4.36
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.34
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.34
Noncoding regions are the main source of targetable tumor-specific antigens 4.29
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.23
Transcriptome profiling of A2M treated A549 Cell Line Samples 4.23
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.2
The transcriptome effect of overexpressing EZH2 in MCF7 4.19
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.99
MCF-7 as a model for functional analysis of breast cancer risk variants 3.95
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 3.91
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.88
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.88
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.88
Differential Protein Occupancy Profiling of the mRNA Transcriptome 3.87
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.87
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.87
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.85
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.85
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.84
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.84
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 3.82
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 3.82
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.78
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.74
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 3.73
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 3.7
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 3.68
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 3.68
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 3.68
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 3.66
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.66
Transcriptional landscape changes during human embryonic stem cell derivation 3.64
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 3.58
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 3.58
Identification of long noncoding RNAs regulated by p53 3.57
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.49
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.47
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 3.46
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 3.45
RNA-seq analysis of gene expression patterns during hESC neural differentiation 3.44
hESC neural differentiation 3.44
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.41
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 3.3
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 3.29
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 3.29
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 3.15
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.15
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.13
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.11
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.1
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.1
Gene expression profile in breast cancer cells 3.02
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.02
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 3.01
Non-coding regions are the main source of tumor-specific antigens 3.01
Non-coding regions are the main source of tumor-specific antigens [human] 3.01
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.98
RNAseq of cell lines with knocked in ESR1 mutations 2.98
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 2.94
Downregulation of LATS kinases alters p53 to promote cell migration 2.91
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.87
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 2.85
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.85
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.8
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.8
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.76
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.65
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.63
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 2.62
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 2.6
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.6
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 2.6
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 2.6
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 2.59
Global gene expression profile of dasatinib-resistant RCH-ACV cells 2.53
The gene expression profiles of gallbladder cancer 2.52
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.5
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.49
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.49
Identification of HOXB13 target genes responsive to BET inhibitors 2.47
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 2.46
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.46
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 2.44
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 2.42
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 2.39
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 2.39
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.3
Human islets of varying quality: the good, the (not so) bad and the ugly 2.18
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.17
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 2.12
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.1
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.08
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 2.04
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.02
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.0
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.97
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.95
Gene expression analysis in response to hypoxic pathway inhibition 1.89
Leucegene: AML sequencing (part 6) 1.89
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.88
Gene profiling of human adult and pediatric liver cancer cells 1.85
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.83
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.81
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 1.75
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.69
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.69
Generation of KRAS signatures using immortalized isogenic lung cells. 1.67
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.67
Transcriptome analysis reveals differential splicing events in IPF lung tissue 1.66
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.62
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.62
RNA-Seq in PWS iPSC-derived neurons 1.61
Transposon-based construction of strand-specific RNA-seq libraries 1.52
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.5
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 1.41
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 1.33
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.23
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.22
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.22
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.22
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.19
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.18
Bone marrow derived human B cells [normal proB] 1.17
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.09
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.03
Exploring ILF2 regulatory genes by next-generation sequencing 1.02
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.97
Transcriptome analysis in Neobractatin treated cells 0.94
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.94
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.9
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.8
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.8
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.78
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.78
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.77
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.65
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.62
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.62
Identification of expressed and conserved human non-coding RNAs 0.62
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.6
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.58
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.58
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.48
RNA seq analysis of human Fetal and adult derived Enterospheres 0.45
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.43
Investigate A2M treatment on human prostate cancer and mouse liver 0.42
Investigate A2M treatment on human prostate cancer xenograft in mice 0.42
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.39
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.39
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.37
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.34
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.31
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.3
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.28
Effect of nuclear IL-33 on gene expression 0.25
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.25
Gene expression analysis of human adenomas. 0.21
SOX11 knockdown in B-ALL cell lines 0.16
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.16
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.13
mRNA-sequencing of breast cancer subtypes and normal tissue 0.11
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.1
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.08
RNAseq of Breast cancer PDX samples 0.08
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 0.06
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.04
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.01
Gene expression analysis of breast cancer cell-lines 0.01
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.01
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.01
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation